BCDA CIK: 925741

BioCardia, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
13.5
FY22:
7.86
FY23:
1.46
FY24:
2.62
FY25:
2.73
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.24
FY22:
1.93
FY23:
1.53
FY24:
1.10
FY25:
0.68
Total assets
Change from FY21 to FY25
millions USD
FY21:
15.7
FY22:
9.79
FY23:
2.99
FY24:
3.72
FY25:
3.41

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.71
FY22:
3.59
FY23:
3.61
FY24:
2.32
FY25:
2.43
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.63
FY22:
1.32
FY23:
0.98
FY24:
0.57
FY25:
0.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.4
FY22:
4.89
FY23:
−1.60
FY24:
0.84
FY25:
0.90
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
15.7
FY22:
9.79
FY23:
2.99
FY24:
3.72
FY25:
3.41

All amounts in millions USD Data sources:SEC EDGARTwelve Data